🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Belgium / NCT06931847
Starting soon Observational

SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New

NCT06931847 · tracked via the Priya Life Science Belgium tracker
Phase
Observational
Started
2025-09
Last updated
2025-04-17

Condition(s) studied

Cancer

Investigational drug(s) / intervention(s)

SUNRISE program

SUNRISE program: The program will use several solutions, each focusing on different aspects of health promotion: * SmartCoach, a mobile phone-based life-skills training program, focuses on self-management, social skills, and substance use resistance. * Social robots and conversational assistants aim to engage students through interactive sessions on health topics like diet and physical activity. * Educational and serious games enhance knowledge and resistance to unhealthy food marketing, providing an engaging way to learn about advertising tactics and healthy eating. * The influencer campaign tackles nutritional misinformation by using content created by influencers to educate adolescents on detecting and critically evaluating misleading health information. * Health and advertisement educational module aims to educate students on recognizing deceptive advertising and making informed choices about their health.

Study summary

SUNRISE aims to create a comprehensive, engaging, and sustainable digital health promotion program that not only addresses immediate health behaviours but also instills lifelong healthy habits among adolescents. By integrating cutting-edge digital tools with traditional educational settings, SUNRISE seeks to bridge the gap between knowledge and practice, making cancer prevention a tangible and achievable goal for young people. This study represents a significant step towards reducing the future burden of cancer through early and innovative preventive measures.

The SUNRISE project aims to test its interventions on students across eight European countries, including Greece, Switzerland, Slovenia, Spain, Cyprus, Italy, Belgium, and Romania. This study focuses on integrating a unique, digitally enhanced program combining different digital solutions with new methods to change adolescent health behaviour through social media campaigns, social bot platforms, educational games, and health-related advertising content into the school environment, targeting students aged 10 to 19 years.

The program emphasizes inclusivity, ensuring participation from both urban and rural regions and socially disadvantaged groups such as ethnic minorities and migrants. By addressing diverse socio-economic, cultural, and environmental contexts, SUNRISE aspires to create a universally applicable and impactful intervention.

Eligibility

Sex
ALL
Min age
10 Years
Max age
19 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Minimum Age: Students must be at least 10 years old at the time of enrolment. * Devices and Internet Access: Students must have access to an electronic device with Internet connectivity. * Informed Consent: Students must provide their signed informed consent to participate in the study. * Parental Consent: Students, when necessary, must obtain and submit signed informed consent from a parent or legal guardian. Exclusion Criteria: * Age Restrictions: Students who are younger than 10 years or older than the established age range for participation. * Consent Issues: Students who have not signed the informed consent form or do not have signed informed consent from their parents or legal guardians. * Follow-up Limitations: Students who are unable to commit to the follow-up period of at least 18 months or are unlikely to complete the study.

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
Ghent University (UGENT) Zürich Belgium
Cyprus Association of Cancer Patients and Friends (PASYKAF) Nicosia Cyprus
Hellenic Mediterranean University (HMU) Heraklion Greece
Italian Federation of Voluntary Associations in Oncology (FAVO) Roma Italy
Institute of Oncology "Prof dr. Ion Chiricuta" CLUJ NAPOCA (IOCN) Cluj-Napoca Romania
Alma Mater Europaea University (AMEU) Maribor Slovenia
Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio) Valencia Spain
Swiss Research Institute for Public Health and Addiction (ISGF) Zurich Switzerland

More Biobizkaia Health Research Institute trials in Belgium

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06931847 on ClinicalTrials.gov ↗ ← All trials in Belgium